首页|期刊导航|Journal of Geriatric Cardiology|Study design and rationale of the TXL-CAP trial:a randomized,double-blind,placebo-controlled,multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques
Study design and rationale of the TXL-CAP trial:a randomized,double-blind,placebo-controlled,multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques
Mei NI Yun TI Yan QI Meng ZHANG Dayue Darrel Duan Chen YAO Zhen-Hua JIA Yun ZHANG Pei-Li BU
Journal of Geriatric Cardiology2025,Vol.22Issue(7):P.615-624,10.
Journal of Geriatric Cardiology2025,Vol.22Issue(7):P.615-624,10.DOI:10.26599/1671-5411.2025.07.004
Study design and rationale of the TXL-CAP trial:a randomized,double-blind,placebo-controlled,multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques
摘要
关键词
coronary atherosclerotic plaques/acute coronary syndrome/Tongxinluo capsules/optical coherence tomography/clinical trials/acute coronary syndrome acs/statin therapytreatment/stabilize coronary lesions分类
医药卫生引用本文复制引用
Mei NI,Yun TI,Yan QI,Meng ZHANG,Dayue Darrel Duan,Chen YAO,Zhen-Hua JIA,Yun ZHANG,Pei-Li BU..Study design and rationale of the TXL-CAP trial:a randomized,double-blind,placebo-controlled,multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques[J].Journal of Geriatric Cardiology,2025,22(7):P.615-624,10.基金项目
National Key Research and Development Program of China(2017YFC1700502) (2017YFC1700502)
Ministry of Science and Technology of China。 ()